The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series

被引:46
作者
Moreira, Daniel M. [1 ,2 ,3 ,4 ]
Anderson, Tiffany [2 ,3 ]
Gerber, Leah [2 ,3 ,4 ]
Thomas, Jean-Alfred [2 ,3 ,4 ]
Banez, Lionel L. [2 ,3 ,4 ]
McKeever, Madeline G. [2 ,3 ,4 ]
Hoyo, Cathrine [6 ]
Grant, Delores [7 ]
Jayachandran, Jayakrishnan [2 ,3 ,4 ]
Freedland, Stephen J. [2 ,3 ,4 ,5 ]
机构
[1] Duke Univ, DUMC, Div Urol, Sch Med, Durham, NC 27710 USA
[2] Duke Univ, Sch Med, Dept Surg, Div Urol Surg, Durham, NC 27710 USA
[3] Duke Univ, Sch Med, Duke Prostate Ctr, Durham, NC 27710 USA
[4] Vet Affairs Med Ctr Durham, Urol Sect, Durham, NC USA
[5] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA
[6] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA
[7] N Carolina Cent Univ, Canc Res Program, JLC Biomed Biotechnol Res Inst, Durham, NC USA
关键词
Prostatic neoplasm; Prostate-specific antigen; Diabetes Mellitus; Incidence; Epidemiology; Case-control studies; Obesity; Population groups; Ethnic groups; Continental population groups; Male; BODY-MASS INDEX; RADICAL PROSTATECTOMY; HOSPITAL DATABASE; RISK; MEN; OBESITY; HEALTH; TRIAL; TESTOSTERONE; METAANALYSIS;
D O I
10.1007/s10552-011-9770-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To analyze the association of diabetes mellitus (DM) with risk of prostate cancer and cancer grade among men undergoing prostate biopsy and to analyze how obesity and race modify these associations. Retrospective analysis of 998 men from the Durham VA undergoing first prostate biopsy between 2001 and 2009 with complete data available. History of DM was determined by chart review. Patients' characteristics at biopsy were analyzed with chi-square and ranksum. Multivariable analyses of DM and risk of cancer and cancer grade were done using logistic regression adjusting for PSA, body mass index, race, age, year, and digital rectal exam. At biopsy, 284 (28%) men had DM. DM was associated with African American (AAM; p = 0.010) and higher BMI (p < 0.001). DM was not associated with prostate cancer risk on either bivariate (p = 0.600) or multivariate analysis (p = 0.485). Similar results were found after stratification by race and obesity. In multivariable analysis, DM was associated with greater risk of high-grade disease (RR = 2.13, p = 0.024). The association was stronger among obese men (RR = 3.84, p = 0.020) and null in non-obese subjects (RR = 1.39, p = 0.460). After further stratification by race, DM was associated with high-grade disease only in obese Caucasian men (CM; RR = 5.81, p = 0.025) but not in obese AAM. DM was not associated with risk of low-grade disease in all men together or after stratification by obesity or race. History of DM was associated with greater risk of high-grade disease. The association was strongest among obese CM suggesting the effect of DM on high-grade prostate cancer is modified by race and obesity.
引用
收藏
页码:977 / 983
页数:7
相关论文
共 28 条
  • [11] Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database
    Freedland, S. J.
    Banez, L. L.
    Sun, L. L.
    Fitzsimons, N. J.
    Moul, J. W.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2009, 12 (03) : 259 - 263
  • [12] Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the shared equal access regional cancer hospital database study group
    Freedland, SJ
    Aronson, WJ
    Kane, CJ
    Presti, JC
    Amling, CL
    Elashoff, D
    Terris, MK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 446 - 453
  • [13] Obesity, diabetes, and risk of prostate cancer: Results from the prostate cancer prevention trial
    Gong, Zhihong
    Neuhouser, Marian L.
    Goodman, Phyllis J.
    Albanes, Demetrius
    Chi, Chen
    Hsing, Ann W.
    Lippman, Scott M.
    Platz, Elizabeth A.
    Pollak, Michael N.
    Thompson, Ian M.
    Kristal, Alan R.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) : 1977 - 1983
  • [14] Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: The multiethnic cohort
    Henderson, Katherine DeLellis
    Goran, Michael I.
    Kolonel, Laurence N.
    Henderson, Brian E.
    Le Marchand, Loic
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (11) : 2298 - 2302
  • [15] Diabetes and Outcomes After Radical Prostatectomy: Are Results Affected by Obesity and Race? Results from the Shared Equal-Access Regional Cancer Hospital Database
    Jayachandran, Jayakrishnan
    Aronson, William J.
    Terris, Martha K.
    Presti, Joseph C., Jr.
    Amling, Christopher L.
    Kane, Christopher J.
    Freedland, Stephen J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (01) : 9 - 17
  • [16] A meta-analysis of diabetes mellitus and the risk of prostate cancer
    Kasper, Jocelyn S.
    Giovannucci, Edward
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (11) : 2056 - 2062
  • [17] Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study
    Kasper, Jocelyn S.
    Liu, Yan
    Giovannucci, Edward
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (06) : 1398 - 1403
  • [18] Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Leitzmann, Michael F.
    Ahn, Jiyoung
    Albanes, Demetrius
    Hsing, Ann W.
    Schatzkin, Arthur
    Chang, Shih-Chen
    Huang, Wen-Yi
    Weiss, Jocelyn M.
    Danforth, Kim N.
    Grubb, Robert L., III
    Andriole, Gerald L.
    [J]. CANCER CAUSES & CONTROL, 2008, 19 (10) : 1267 - 1276
  • [19] Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
    Ma, Jing
    Li, Haojie
    Giovannucci, Ed
    Mucci, Lorelei
    Qiu, Weiliang
    Nguyen, Paul L.
    Gaziano, J. Michael
    Pollak, Michael
    Stampfer, Meir J.
    [J]. LANCET ONCOLOGY, 2008, 9 (11) : 1039 - 1047
  • [20] Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
    Mantzoros, CS
    Tzonou, A
    Signorello, LB
    Stampfer, M
    Trichopoulos, D
    Adaml, HO
    [J]. BRITISH JOURNAL OF CANCER, 1997, 76 (09) : 1115 - 1118